KAS
PCRX icon

Kestra Advisory Services’s Pacira BioSciences PCRX Stock Holding History

Kestra Advisory Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,869
Closed -$48.4K – 4040
2025
Q4 		$48.4K Buy
+1,869
New +$44.4K ﹤0.01% 3961
2025
Q2 		– Sell
-11,852
Closed -$295K – 2946
2025
Q1 		$295K Sell
11,852
-4,044
-25% -$96.8K ﹤0.01% 2181
2024
Q4 		$299K Buy
+15,896
New +$279K ﹤0.01% 2219
2021
Q2 		– Sell
-3,672
Closed -$257K – 2026
2021
Q1 		$257K Buy
3,672
+111
+3% +$7.93K ﹤0.01% 1563
2020
Q4 		$209K Buy
+3,561
New +$209K ﹤0.01% 1693

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return